A simple method for determining acetylator phenotype using isoniazid

British Journal of Clinical Pharmacology
A Hutchings, P A Routledge

Abstract

A comparison was made between the results of acetylator phenotyping by isoniazid (INH) half-life measurements based on samples taken for 6 h after a single oral dose (200 mg), and by determination of the ratio of acetylisoniazid (Ac.INH) to isoniazid in the 3 h samples. In the 32 subjects, examined, there was complete agreement about classification of the subject as a fast (t1/2 less than 130 min; Ac.INH/INH greater than 1.5) or slow acetylator (t1/2 greater than 130 min; Ac.INH/INH less than 1.5). The single sample test appears to be as reliable as the more time-consuming isoniazid half-life method.

References

Nov 1, 1979·Clinical Pharmacokinetics·W W Weber, D W Hein
Feb 1, 1983·British Journal of Clinical Pharmacology·A HutchingsP A Routledge
Jul 1, 1981·British Journal of Clinical Pharmacology·R A AhmadP Wright
Jan 1, 1981·European Journal of Clinical Pharmacology·A HansonE Wåhlin-Boll
Aug 13, 1960·British Medical Journal·D A EVANSV A McKUSICK

❮ Previous
Next ❯

Citations

Nov 30, 2004·European Journal of Clinical Pharmacology·R G DattaniP A Routledge
Feb 27, 2010·European Journal of Clinical Pharmacology·Hossein KhaliliMahboobeh Hajiabdolbaghi
Jan 1, 1989·Pharmacology & Therapeutics·D A Evans
Feb 1, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·L Aït MoussaB Hüe
May 1, 2013·Antimicrobial Agents and Chemotherapy·Alma TostmannRob E Aarnoutse
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·K GallicanoA Pakuts
Jan 1, 1996·Drug Metabolism and Drug Interactions·L A Damani, I P Nnane
Jul 1, 2006·Journal of Clinical Pharmacology·Robert J StrakaMichael Y Tsai
May 1, 1988·British Journal of Clinical Pharmacology·A D HutchingsP A Routledge
Jul 1, 1988·British Journal of Clinical Pharmacology·M D LittleyJ H Lazarus
Nov 22, 2005·Mechanisms of Ageing and Development·Ismael Lares-AsseffGabriela Pérez
Aug 14, 2001·Pharmacoepidemiology and Drug Safety·H I SeifartB J Van Der Walt
Nov 14, 1997·Clinical Pharmacology and Therapeutics·A Pariente-KhayatG Pons
Mar 5, 1998·Therapeutic Drug Monitoring·E ReyD Gendrel
Oct 28, 2019·The Journal of Antimicrobial Chemotherapy·Charles M MtabhoRob E Aarnoutse
Mar 22, 2005·Psychopharmacology·Oliver FreudenreichDonald C Goff
Jun 11, 2017·Psychopharmacology·Walter RobertsSherry A McKee
Sep 9, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lara A RayKaren Miotto
Mar 1, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Barbara J MasonSantosh Rao
Nov 1, 1996·British Journal of Clinical Pharmacology·A D Hutchings, P A Routledge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

British Journal of Clinical Pharmacology
A HutchingsP A Routledge
European Journal of Clinical Pharmacology
A HansonE Wåhlin-Boll
British Journal of Clinical Pharmacology
A Hutchings, P A Routledge
International Journal of Clinical Pharmacology and Therapeutics
L Aït MoussaR Soulaymani
British Journal of Clinical Pharmacology
A HutchingsP A Routledge
© 2021 Meta ULC. All rights reserved